JP7688471B2 - アディポネクチンペプチド模倣組成物 - Google Patents

アディポネクチンペプチド模倣組成物 Download PDF

Info

Publication number
JP7688471B2
JP7688471B2 JP2021522507A JP2021522507A JP7688471B2 JP 7688471 B2 JP7688471 B2 JP 7688471B2 JP 2021522507 A JP2021522507 A JP 2021522507A JP 2021522507 A JP2021522507 A JP 2021522507A JP 7688471 B2 JP7688471 B2 JP 7688471B2
Authority
JP
Japan
Prior art keywords
composition
ser
eye
weight
propylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021522507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022505832A (ja
JP2022505832A5 (enExample
Inventor
ピー バーマン，シッカ
エル ワード，ケヴィン
チェン，ユガン
Original Assignee
アリスタ ファーマスーティカルス インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アリスタ ファーマスーティカルス インク． filed Critical アリスタ ファーマスーティカルス インク．
Publication of JP2022505832A publication Critical patent/JP2022505832A/ja
Priority to JP2024160067A priority Critical patent/JP2024178262A/ja
Publication of JP2022505832A5 publication Critical patent/JP2022505832A5/ja
Application granted granted Critical
Publication of JP7688471B2 publication Critical patent/JP7688471B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP2021522507A 2018-10-24 2019-10-24 アディポネクチンペプチド模倣組成物 Active JP7688471B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024160067A JP2024178262A (ja) 2018-10-24 2024-09-17 アディポネクチンペプチド模倣組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862749861P 2018-10-24 2018-10-24
US62/749,861 2018-10-24
PCT/US2019/057876 WO2020086856A1 (en) 2018-10-24 2019-10-24 Adiponectin peptidomimetics formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024160067A Division JP2024178262A (ja) 2018-10-24 2024-09-17 アディポネクチンペプチド模倣組成物

Publications (3)

Publication Number Publication Date
JP2022505832A JP2022505832A (ja) 2022-01-14
JP2022505832A5 JP2022505832A5 (enExample) 2024-10-07
JP7688471B2 true JP7688471B2 (ja) 2025-06-04

Family

ID=70326409

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021522507A Active JP7688471B2 (ja) 2018-10-24 2019-10-24 アディポネクチンペプチド模倣組成物
JP2024160067A Pending JP2024178262A (ja) 2018-10-24 2024-09-17 アディポネクチンペプチド模倣組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024160067A Pending JP2024178262A (ja) 2018-10-24 2024-09-17 アディポネクチンペプチド模倣組成物

Country Status (11)

Country Link
US (2) US12201668B2 (enExample)
EP (1) EP3870204A4 (enExample)
JP (2) JP7688471B2 (enExample)
KR (1) KR20210118810A (enExample)
CN (1) CN113164551A (enExample)
AU (1) AU2019363588A1 (enExample)
CA (1) CA3116065A1 (enExample)
IL (1) IL282390A (enExample)
SG (1) SG11202103947XA (enExample)
TW (1) TWI921299B (enExample)
WO (1) WO2020086856A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024178262A (ja) * 2018-10-24 2024-12-24 アリスタ ファーマスーティカルス インク． アディポネクチンペプチド模倣組成物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240382564A1 (en) * 2023-04-17 2024-11-21 Allysta Pharmaceuticals, Inc. Methods and Compositions for Treating Muscular Dystrophy and Memory Impairment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140057833A1 (en) 2011-04-12 2014-02-27 Temple University-Of The Commonwealth System Of Higher Education Adiponectin receptor agonists and methods of use
JP2018503595A (ja) 2014-09-24 2018-02-08 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその製剤
JP2018514592A (ja) 2015-05-01 2018-06-07 アリスタ ファーマスーティカルス インク． 眼疾患を治療するためのアディポネクチンペプチド模倣薬（関連出願の相互参照）

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333850T3 (de) * 1992-05-06 2011-03-17 Alcon Laboratories, Inc., Fort Worth Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US11078262B2 (en) * 2007-04-30 2021-08-03 Allergan, Inc. High viscosity macromolecular compositions for treating ocular conditions
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
AU2015317531B2 (en) * 2014-09-17 2020-11-19 Panoptica, Inc. Ocular formulations for drug-delivery and protection of the anterior segment of the eye
CN113164551A (zh) * 2018-10-24 2021-07-23 雅利斯塔制药公司 脂联素肽模拟物制剂

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140057833A1 (en) 2011-04-12 2014-02-27 Temple University-Of The Commonwealth System Of Higher Education Adiponectin receptor agonists and methods of use
JP2018503595A (ja) 2014-09-24 2018-02-08 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその製剤
JP2018514592A (ja) 2015-05-01 2018-06-07 アリスタ ファーマスーティカルス インク． 眼疾患を治療するためのアディポネクチンペプチド模倣薬（関連出願の相互参照）

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024178262A (ja) * 2018-10-24 2024-12-24 アリスタ ファーマスーティカルス インク． アディポネクチンペプチド模倣組成物

Also Published As

Publication number Publication date
AU2019363588A1 (en) 2021-05-13
IL282390A (en) 2021-06-30
TWI921299B (zh) 2026-04-11
US20200129585A1 (en) 2020-04-30
EP3870204A1 (en) 2021-09-01
SG11202103947XA (en) 2021-05-28
JP2022505832A (ja) 2022-01-14
KR20210118810A (ko) 2021-10-01
US20250099533A1 (en) 2025-03-27
JP2024178262A (ja) 2024-12-24
WO2020086856A1 (en) 2020-04-30
US12201668B2 (en) 2025-01-21
CA3116065A1 (en) 2020-04-30
CN113164551A (zh) 2021-07-23
TW202033213A (zh) 2020-09-16
EP3870204A4 (en) 2022-12-21

Similar Documents

Publication Publication Date Title
US11464825B2 (en) Adiponectin peptidomimetics for treating ocular disorders
US20250099533A1 (en) Adiponectin peptidomimetics formulations
HK40058825A (en) Adiponectin peptidomimetics formulations
HK40027227A (en) Adiponectin peptidomimetics for treating ocular disorders
JP2020535117A (ja) 眼疾患を治療するためのアディポネクチンペプチド模倣薬
HK1246178B (en) Adiponectin peptidomimetics for treating ocular disorders

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221007

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230809

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231102

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240209

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240516

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240917

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20240917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240930

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20241001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250205

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250508

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250521

R150 Certificate of patent or registration of utility model

Ref document number: 7688471

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150